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Objectives. To review studies on newborn hearing screening in Hong Kong
and the current evidence on the cost-effectiveness of universal newborn hearing
screening programmes and to determine their value and the best model for such
a programme in Hong Kong.
Data source. Medline literature search (1985-2004), local reports and abstracts
available to the author.
Study selection. Literature and data on newborn hearing screening strategies,
screening devices, cost-effectiveness study of universal newborn hearing
screening programmes.
Data extraction. Relevant information and data were reviewed by the author.
Data synthesis. A universal newborn hearing screening programme with a
high coverage rate is essential to enable early diagnosis and intervention before
6 months of age. This ensures good language and cognitive outcomes in hearing
impaired children. A cost-effective universal newborn hearing screening
programme should be hospital-based to achieve a high coverage rate, use
modern screening devices with high sensitivity and specificity that enable early
diagnosis, and be acceptable to parents.
Conclusions. Increasing evidence supports the cost-effectiveness and long-term
benefits of universal newborn hearing screening programmes. The medical
community in Hong Kong should work towards the development and implemen-
tation of a well-coordinated, collaborative, multidisciplinary, cost-effective, and
sustainable territory-wide universal newborn hearing screening programme
coupled with interventions for the next generation of hearing impaired children.
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Introduction
Significant hearing impairment (HI) is an important and common birth defect
that occurs in 1 to 3 per 1000 live births and 2 to 4 per 100 neonatal intensive
care infants.1-4 It occurs more frequently than many other newborn conditions for
which screening is routinely performed, for example congenital hypothyroidism.
Based on an annual birth rate of 55 000 in Hong Kong, about 165 infants were
born with significant HI.5
Children with HI are deprived of an important source of sensory input. The
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auditory stimuli that a child perceives in the first few months
of life form the basis of speech, language, and cognitive
development. If lacking, social, emotional, comprehensive,
and motor development can be adversely affected. One third
of children with even minimal hearing loss fail at least one
grade and exhibit social and/or emotional problems by the
time they reach the fourth grade.6 Despite advances in hear-
ing aid technology, improved educational techniques, and
intensive intervention services available to children with HI,
there has been little advancement in their language devel-
opment and academic performance.7,8 This may be due to
late diagnosis: several prospective studies have consistently
demonstrated that early diagnosis of HI and intervention
can improve intellectual, language, and speech develop-
ment.9-11 One study reported that the only significant vari-
able to affect development of language skills was the age at
which HI was diagnosed.12 Children in whom hearing loss
was identified by 6 months of age demonstrated significantly
better language scores than those in whom it was diagnosed
later. Landmark studies reveal that universal newborn
hearing screening (UNHS) enables early identification and
intervention prior to 6 months of age, such that near-age
appropriate language skills and academic performance can
be achieved.13 Recent advances in the area of hearing screen-
ing have facilitated the availability of more sensitive and
easy-to-use screening tools that can effectively and reliably
test hearing soon after birth. Thus, this issue has recently
been hotly debated and many Asian countries have begun
to develop and report studies of different models of new-
born hearing screening and rehabilitation programmes.14-17
Past experience and limitations of the distraction
test as a screening tool
Hearing screening is an integral component of the
comprehensive observation scheme and was implemented
in Maternal and Child Health Centres (MCHC) in 1978.
The behavioural distraction test is the principal means by
which infant hearing is tested and is performed between
the ages of 6 and 9 months on all children who attend the
MCHC. One of the major limitations of this screening
method is the validity of the test: it has poor sensitivity and
low specificity. In the United Kingdom, the distraction test
performed at 8 months has a reported failure rate of up to
16.3%,18 and is difficult to perform and unreliable in high-
risk infants. Such infants may have physical or mental
handicaps that interfere with their ability to respond to
the test. Distraction tests are also time-consuming and
must be performed by trained and experienced staff. In
addition, the criteria for determining presence or absence
of a reaction are somewhat subjective. In an infant who
fails the first test, a re-test several weeks later is generally
recommended because of the possible presence of
temporary middle ear problems. Despite this, many
hearing impaired children are either not diagnosed or are
diagnosed late. Data collected by the MCHC in Hong Kong
reveal that the usual age at diagnosis, especially for
children without risk factors, is 18 months to 2 years, with
most infants receiving treatment and rehabilitation after
2 years of age. The uptake of hearing screening for newborns
registered at the centre was 81.7%, far below the required
rate of more than 95% needed for any form of universal
health screening. Nonetheless with this programme, the yield
of babies with moderate or severe HI bilaterally is 0.2 per
1000, which is far less than expected.19
High-risk newborn hearing screening
The 1994 Position Statement of the American Academy
of Pediatrics Joint Committee on Infant Hearing20
recommended the maintenance of a role for high-risk
indicators associated with sensorineural and/or conductive
hearing loss in newborns and infants and modified the list
of indicators described in the 1990 Position Statement.
The Committee recommends a specific hearing protocol for
high-risk infants when universal screening is unavailable.
The indicators associated with hearing loss for use with
neonates are:
(1) family history of hereditary childhood sensorineural
hearing loss;
(2) in-utero infection, such as cytomegalovirus, rubella,
syphilis, herpes, and toxoplasmosis;
(3) craniofacial anomalies, including those with morpho-
logical abnormalities of the pinna and ear canal;
(4) birth weight of less than 1500 g (3.3 lb);
(5) hyperbilirubinaemia at a serum level requiring
exchange transfusion;
(6) ototoxic medications, including but not limited to
aminoglycosides used in multiple courses or in com-
bination with loop diuretics;
(7) bacterial meningitis;
(8) Apgar scores of 0 to 4 at 1 minute or 0 to 6 at 5 minutes;
(9) mechanical ventilation lasting 5 days or longer; and
(10) stigmata or other findings associated with a syndrome
known to include sensorineural and/or conductive
hearing loss.
In Hong Kong, most Hospital Authority (HA) birthing
hospitals perform some form of hearing tests for at-risk
infants, usually by brainstem auditory evoked potential
(BAEP) or by otoacoustic emission (OAE) tests. These
screening programmes nevertheless do not form part of a
territory-wide protocol and are often uncoordinated with no
formal tracking or follow-up system.
The first high-risk newborn hearing screening pro-
gramme in Hong Kong in 1998 identified 5% of babies born
at the hospital to be at risk, of whom 3.8% were confirmed
to have hearing loss using conventional auditory brainstem
response tests.21 Five years ago, a large-scale high-risk
hearing screening project was conducted in Hong Kong and
involved a birth cohort of 19 922 babies from five major
public hospitals.22 Risk factors were based on the high-risk
indicators modified from the American Joint Committee on
Infant Hearing 1990 Position Statement.23 Screening was
performed using a two-stage distortion product OAE test
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214      Hong Kong Med J Vol 12 No 3 June 2006
(a)
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(DPOAE; Otodynamics ILO 292 Echoport System, Welch
Allyn, US). Conventional auditory brainstem response tests
were performed in infants who failed the OAE test twice
and those with central nervous system risk factors. Only
2.7% of infants were identified to have risk factors. This
relatively low rate indicates that many of the risk factors
(eg congenital infections, subtle craniofacial abnormalities,
family history of hearing problems) might go undetected.
This implies that the high-risk indicators are unreliable as a
means of determining the individual need for newborn
hearing screening. In these at-risk infants, the overall rate
of HI in general was 4.5% and of moderate-to-profound HI
2.4%. Hence, the overall prevalence of moderate-to-
profound HI was 0.6 per 1000 births; much lower than the
reported prevalence of 1 to 3 per 1000.1-4 Previous studies
also confirm that high-risk screening is ineffective because
it may miss at least 50% of children with congenital HI.24,25
A UNHS may therefore offer a more rigorous approach that
can achieve the aim of identifying most, if not all, babies
with congenital hearing loss.
Universal newborn hearing screening
The Joint Committee on Infant Hearing 2000 Position
Statement23 endorsed early detection of, and intervention
for infants with hearing loss through integrated and
interdisciplinary state, and national systems of UNHS,
and family-centred intervention. The purpose of early
detection of hearing problems and intervention is to
maximise linguistic and communicative competence
and liberal development for children who are hearing
impaired.23 The American Academy of Pediatrics Task
Force on Newborn and Infant Hearing recommended that
universal detection of infant hearing loss requires universal
screening of all infants.26 Reliance on a physician’s obser-
vation or parental recognition has not been very successful.
At least five criteria must be fulfilled before universal screen-
ing is justified: (1) the availability of an easy-to-use test
that possesses a high degree of sensitivity and specificity
to minimise referral for additional assessment; (2) the
condition being screened for is otherwise undetectable by
clinical parameters; (3) there are interventions available to
correct the conditions detected by screening; (4) early
screening, detection, and intervention result in improved
outcome; and (5) the screening programme is documented
to be cost-effective. Current available evidence confirms
that a newborn hearing screening programme fulfills
most of these criteria. The American Academy of Pediatrics
also recommended five essential elements of an effective
UNHS programme: screening, tracking and follow-up,
identification, intervention, and evaluation.27,28
Common devices used for universal newborn
hearing screening
Brainstem auditory evoked potential
The conventional BAEP is the most reliable method and the
gold standard for evaluating peripheral auditory function of
a newborn.29,30 It is based on a click stimulus to elicit an
electrical response that is measured by surface electrodes.
It should be performed and the results interpreted by a
skilled technician, usually an audiologist. It also requires
sedation of the baby for the procedure. Hence, due to
the relatively high cost, conventional BAEP is not
recommended as a screening test, but more commonly used
as a diagnostic or confirmatory test.
Otoacoustic emission
At present, the choice of device for newborn hearing
screening is between OAE and automated brainstem
response (ABR), or a combination of the two. Two forms of
OAE technology have been used: ‘transient or click-evoked
otoacoustic emissions’ (TEOAE) and DPOAE. The
differences stem from the choice of stimulus and the
technology subsequently used to extract the response. Both
are based on low-intensity sounds generated by the motile
activity of the outer hair cells in the cochlea and detected
by a microphone applied to the external meatus. The TEOAE
employs click stimulation and averaging similar to
screening by ABR where the response follows the stimulus.
The DPOAE employs a series of tonal stimuli and the
response occurs during the presentation of stimulus. Both
OAE forms have the advantage of being simple and
quick to perform with minimal disturbance to the
babies. Commercially available devices have built-in full
automation making interpretation easy. Appropriately
trained nurses or health care assistants can perform the test
so that, combined with the low-cost consumables, the cost
per test is affordable. Nonetheless, if the ear probes are
not carefully fixed or acoustically shielded, which can be
difficult to achieve in small infants, these tests may be
affected by ambient noise. The noisy environment of
postnatal wards or out-patient clinics where the test is
frequently performed, produces a high number of false-
positive results because the noise interferes the delivery of
stimulus. The false-positive rate is also high when the test is
performed in the first few days of life (due to the presence
of debris in the external ear canal and middle ear).31,32 The
early discharge policy of most birthing hospitals further
limits its use as a hospital-based screening tool. Repeating
the test later (making it a two-stage OAE) may overcome
some of these problems. Moreover, the device can only test
up to the level of cochlea; it does not provide information
on retrocochlear pathology in the auditory nerve, brainstem,
and auditory cortex. Hence babies with risk factors for
neurological disorders may show a normal OAE response
and need additional screening by ABR. Despite this,
OAE is still considered to be of value for screening large
numbers of healthy infants because a very high proportion
of congenital HI is related to pathology in the middle ear or
the sensory cells of the inner ear. Depending on the
above factors, the overall referral rate following OAE for
diagnostic tests varies from 2.4% to 10%.33,34
Automated auditory brainstem response
The automated auditory brainstem response (AABR)
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test, a simplified version of ABR, comprises an
electroencephalography system, a stimulus-generating
system, ambient noise and myogenic activity detection
systems, and the ABR detection algorithm with automation
in result interpretation. It is tested by delivering a soft click
to the baby’s ear through ear probes. The electrical response
is picked up by disposable electrodes attached to the
baby’s skin over the head and neck region. Signals from
the skin electrodes are then transmitted to the computer for
averaging and automatic analysis. This is a quick and
simple test that can be performed reliably even in
newborns under 24 hours old, and is thus ideally suited as
a hospital-based screening programme. It has a lower
referral rate, ranging from 4% to 0.82%. The two-stage
AABR can further reduce the referral rate to between 2.5%
and 0.12%.35-37 The currently available AABR machine
and its consumables are nonetheless more expensive than
the OAE device, which inevitably increases the cost of a
screening.
The recent introduction of equipment that incorporates
both OAE and ABR functions provides an additional
option for screening. The former measures the health of the
cochlear and the hair cells, and the latter tests the health of
the neurons within the auditory brainstem structures. A
two-stage OAE-ABR enables a complete evaluation of the
baby’s auditory function and achieves a low referral rate for
further diagnostic evaluation.
Regardless of the device and method chosen, a success-
ful hearing screening programme requires an accurate,
rapid, and simple-to-conduct test that can, preferably,
be fully automated and provided at an affordable cost. A
feasibility study based on the local setting and experience
is essential before a screening programme is widely
implemented.
Pilot studies of hospital-based universal newborn
hearing screening in Hong Kong
The first pilot study of a UNHS programme was performed
in a university hospital (Tsan Yuk Hospital) over a 4-month
period in 1999.38 The study was undertaken to investigate
the prevalence of HI, to assess the feasibility of implement-
ing a UNHS programme in a maternity hospital, and to
explore parental understanding of the detection of hearing
loss in young infants and parental acceptability of newborn
hearing screening. The screening was performed using
a two-stage DPOAE (Otodynamics ILO 292 Echoport
System). Results demonstrated a high coverage rate of
99.3% and a prevalence of permanent bilateral HI of 0.28%.
It was noted that the referral rate for diagnostic testing was
unacceptably high when the test was performed within the
first 3 days of life before hospital discharge. This confirmed
previous experience that OAE may have high false-positive
rates because of ear debris when performed within a few
days of birth. The questionnaire study also showed that most
parents had little understanding of hearing developmental
milestones. Parental surveillance cannot therefore be
considered a reliable means to detect hearing problem in
newborns. Most (91%) mothers agreed neonatal screening
for hearing defects was desirable and most (82%) preferred
such screening to be carried out before discharge from
the maternity unit. This study demonstrated that the
implementation of hospital-based UNHS in Hong Kong is
feasible and acceptable to parents. Further study is
necessary to explore the use of other screening devices
that may have a lower referral rate for diagnostic screening
before hospital discharge.
In 2000, the HA set up a multidisciplinary working
group that included paediatricians, audiologists, and
otolaryngologists to consider the justification and the
logistics of establishing a UNHS programme in Hong Kong.
Another pilot study was conducted in three major public
hospitals and involved a birth cohort of 4314 over a 5-month
period in 2001.39 The study aimed to assess the referral
rates of different screening protocols, namely (1) two-stage
AABR using ALGO2 (Natus Medical, CA, US), (2)
two-stage OAE-AABR using Bio-logic 2-in-1 screener
(Mundelein, IL, US), and (3) two-stage AABR using Bio-
logic 2-in-1 screener. The tests were completed before
the babies were discharged from hospital with an overall
coverage rate of 89.6%. In two hospitals, where the projects
were coordinated by paediatricians, a higher coverage
rate of over 95% was achieved. The referral rates of
AABR-AABR (ALGO2) protocol were consistently shown
across the three hospitals to be the lowest compared with
OAE-AABR (Bio-logic) and AABR-AABR (Bio-logic).
This study confirmed that UNHS is feasible. A well-
coordinated hospital-based screening programme can
achieve a high coverage rate and the two-stage AABR
screening with ALGO2 yields the lowest referral rates. An
earlier study40 also showed that an AABR programme has
the lowest referral rate. The referral rate of 0.6% at the
second stage in this study was much lower than the reported
referral rate of 3.2%.37 Although the AABR programme has
more expensive consumables, the lower referral rate means
that the cost per infant screened is similar among all three
programmes. If dedicated technicians are used, as in this
study, referral rates and overall costs should also drop
significantly.
Pilot study of community-based universal
newborn hearing screening in the Maternal and
Child Health Centres in Hong Kong
The MCHC of the Department of Health investigated the
use of two-stage OAE to replace the distraction test.19 As
not all births are registered at the regional MCHC, the
coverage rate for the total birth cohort was unknown. This
study showed a coverage rate of 72.5% of all babies
registered at the four study centres. The most common
reason for babies not receiving the test was that they were
older than 2 months at registration. The test repeat rate was
9.2% and screen referral rate was 3.8%. The yield for
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moderate or severe HI was 0.76 per 1000 babies screened.
This study confirmed that screening performed in the MCHC
setting after discharge from birthing hospitals cannot achieve
a standard coverage rate of 95% as laid down in the Joint
Committee on Infant Hearing 2000 Position Statement.23
The referral rate of the OAE, although lower than in the
hospital screening, was much higher than the hospital-based
two-stage AABR screening protocol.
Cost-effectiveness and parental stress of a
universal newborn hearing screening programme
One of the major concerns among the health care adminis-
trators and opponents of UNHS is the cost-effectiveness
and lack of solid evidence to confirm the long-term benefit
to affected children. A meta-analysis of the effects of
screening, early identification, and treatment on language
outcome cautioned that there were several gaps in
information about UNHS.41 Among 19 studies identified,
only one was a controlled trial. Besides, when screening
ensued before the age of 6 months, most studies demon-
strating improved language and communication skills
by the age of 2 to 5 years were based on ‘fair’ to ‘poor’
quality cohort studies. Based on a theoretical mathematical
model devised from this literature review, extending
screening to low-risk infants would detect one additional
case before the age of 10 months for every 1441 low-risk
infants (number needed to screen). In addition, 254 newborns
would need further audiological evaluation because of
false-positive screening results. The meta-analysis cautioned
about the potential harm associated with false-positive
screening including misdiagnosis, parental misunderstand-
ing and anxiety, and unfavourable labelling. Nonetheless,
using the latest technology, data from our local and other
international studies using the AABR demonstrated
sensitivity in the range of 80% to 90%, with a false-positive
rate of less than 2%.39,42 With such a low referral rate, UNHS
is both efficient and cost-effective.43 The proposed costs
are much lower than the costs of the infant distraction
screening test and the cost per child diagnosed with
bilateral permanent HI is considerably less. There is an
increasing body of evidence to confirm that early identifi-
cation of HI and intervention by 6 months of age is associ-
ated with better expressive and receptive language, speech
as well as social and emotional development in the first 5
years of life.44,45 Recent evidence also confirms that UNHS
can reduce the age of confirmation of congenital HI46 and
enable earlier intervention and hearing aid fitting, especially
in infants without risk factors.47 With respect to parental
stress, a study by Weichbold et al48 showed that if parents
were well informed about the hearing test, the vast majority
(84% of mothers) would respond positively to the question
of “should UNHS be performed despite the possibility that
parents become worried by false-positive test results?”.
Similar to our experience in the first hospital-based pilot
UNHS study using the OAE, the general attitude among
parents was very positive, despite the relatively high
false-positive rate in the first stage of screening.38 Another
study has also shown that the anxiety arising from false-
positives and re-testing can be minimised by using screen-
ing tools with lower referral rates, improved information,
and rapid and effective follow-up.49 Hence with a well-
coordinated and well-informed UNHS programme, there
is little to worry that screening all newborns causes unneces-
sary anxiety among mothers.50
Collaborative model for a universal newborn
hearing screening programme
It is important to emphasise that screening is only the
starting point of an effective hearing screening and
intervention programme. The Joint Committee on Infant
Hearing 2000 Position Statement23 sets down the other
important parameters of a UNHS programme: a tracking
and follow-up programme should aim to achieve a
minimum of 95% successful follow-up of all infants referred
for formal audiological assessment and for all infants not
screened initially at the birthing hospital. It is essential to
establish and maintain a central monitoring system for
early identification and intervention, as well as to provide
ongoing and regular evaluation of the performance of
UNHS programmes.
A collaborative programme that incorporates the
specific competencies of the hospital, the MCHC service,
and the education authority is the best collaborative model.
In Hong Kong, almost all babies are born in hospitals. To
achieve a high coverage rate, the test is best performed
when the population is still captive, ie before hospital
discharge. Hospital-based universal screening can achieve
a much higher coverage than the distraction test and OAE
screening programme at MCHC. The birthing hospital, apart
from providing the screening service, can offer specialist
support including audiologists, otolaryngologists for
counselling, and further audiological assessment and
genetic workup for abnormal cases. Paediatricians should
coordinate and ensure access to appropriate expert services
for all affected children. The MCHC should establish and
maintain a central registry and monitoring system. They
should also provide a ‘mop-up’ service for missed cases and
ongoing monitoring for late or acquired HI. Some infants
may pass the initial hearing screening but require periodic
monitoring to detect delayed onset sensorineural and/or
conductive hearing loss. Even inherited causes of HI
may manifest postnatally as late progressive HI. It is well
documented that screening newborn babies with congenital
cytomegalovirus infection may detect less than half of
those with sensorineural hearing loss.51 Hence the MCHC
should maintain a well-documented screening history
and provide ongoing surveillance for those who pass the
test at birth or have mild HI, especially those considered at
risk for whom regular audiological monitoring should con-
tinue until 3 years of age.52 The Joint Committee on Infant
Hearing 1994 Position Statement20 produced a list of health
indicators associated with delayed sensorineural/conductive
hearing loss that warrant re-screening:
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(1) family history of hereditary childhood hearing loss;
(2) in-utero infection, such as cytomegalovirus, rubella,
syphilis, herpes, or toxoplasmosis;
(3) neurofibromatosis type II and neurodegenerative
disorders;
(4) recurrent otitis media with effusion; and
(5) anatomical deformities and other disorders that affect
Eustachian tube function.
Screening should be followed by evaluation, diagnostic
workup, and a multidisciplinary intervention and rehabili-
tation programme. Upon confirmation by diagnostic test and
assessment by audiologists and otolaryngologists, children
with HI should be referred for prompt intervention and
rehabilitation. In Hong Kong, The Audiological Services
Section of the Education Department provides support
to preschool and school-age children with HI.53 In addition
to the provision of hearing devices, parental guidance,
planning of an individualised habilitation programme, and
review of school placement are important and ensure
that these children with HI benefit maximally from early
diagnosis. This undoubtedly presents a challenge to those
involved and requires gradual accumulation and refinement
of expertise relevant to the implementation of universal
screening. Any UNHS is a multidisciplinary programme and
will involve paediatricians, audiologists, otolaryngologists,
nurses, speech therapists, community health care workers,
and education specialists.
Conclusions
A comprehensive universal hearing screening and interven-
tion programme is undoubtedly costly. To ensure an
equitable service, a territory-wide protocol has to be
developed. It is important to ensure that all the involved
professions are committed to a ‘seamless’ collaboration
that is responsive to families’ real needs. Good communi-
cation between all involved parties and the provision of
appropriate information for parents to enable informed
choices is vital. There should be a mechanism that ensures
accessibility to high-quality audiological and rehabilitation
services. The health authority should maintain quality,
territory-wide data for service evaluation and be able to
integrate the same with other child health services. This
will facilitate monitoring for later development of
permanent HI and the effectiveness of the screening
programme. The implementation of a UNHS and rehabili-
tation programme in Hong Kong is feasible. Nonetheless,
with current financial restraints and the compartmentalised
health care and education system, it may be considered an
ambitious endeavour that requires a substantial commitment
of health care resources, energy, and coordination.
Paediatricians, as child health advocates, should work
towards the development and implementation of a well-
coordinated, collaborative, multidisciplinary, cost-effective,
and sustainable territory-wide UNHS and early interven-
tion programme for our next generation of hearing impaired
children.
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